Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.18 USD | +0.40% |
|
+6.75% | -13.70% |
Jul. 11 | KeyBanc Adjusts Price Target on Certara to $20 From $23, Maintains Overweight Rating | MT |
Jul. 09 | Certara Buys Cheminformatics Software Firm, Expanding Drug-Discovery Offerings | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.70% | 2.44B | |
+20.65% | 3,371B | |
+19.25% | 94.08B | |
+15.90% | 86.55B | |
+63.45% | 62.51B | |
-22.05% | 49.4B | |
+38.19% | 48.66B | |
-23.72% | 47.23B | |
+82.30% | 42.4B | |
-4.72% | 26.84B |
- Stock Market
- Equities
- CERT Stock
- News Certara, Inc.
- Certara Buys Cheminformatics Software Firm, Expanding Drug-Discovery Offerings